What's Happening?
Swiss startup Planetary has successfully raised $28 million to enhance its fermentation infrastructure and licensing platform. The funding round, led by Radikal Capital and Oetker Ventures, includes $20 million in equity financing and $7.5 million in credit.
Planetary's business model focuses on producing mycoprotein as a B2B ingredient and licensing its 'BioBlocks' fermentation platform. This platform allows partners to convert low-value side streams into high-value ingredients. The company is currently producing mycoprotein using Fusarium venenatum, a fungi strain with global regulatory approval. Planetary plans to expand its product offerings to include private-label meat and dairy alternatives, as well as hybrid meat applications. The company is also exploring collaborations to produce mycoprotein at industrial scale in India.
Why It's Important?
Planetary's expansion reflects a growing interest in sustainable and innovative food production methods. By focusing on fermentation technology, the company is positioned to meet the increasing demand for alternative protein sources. The investment highlights the potential of fermentation as a viable solution for producing high-quality, cost-effective food ingredients. This development could have significant implications for the food industry, particularly in the context of rising consumer interest in sustainable and health-conscious products. Planetary's approach also underscores the importance of controlling production infrastructure to achieve cost parity with traditional protein sources.
